• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症导致慢性肾病患者血浆氨基酸浓度降低。

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.

作者信息

Suliman Mohammed E, Qureshi A Rashid, Stenvinkel Peter, Pecoits-Filho Roberto, Bárány Peter, Heimbürger Olof, Anderstam Björn, Rodríguez Ayala Ernesto, Divino Filho José C, Alvestrand Anders, Lindholm Bengt

机构信息

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

出版信息

Am J Clin Nutr. 2005 Aug;82(2):342-9. doi: 10.1093/ajcn.82.2.342.

DOI:10.1093/ajcn.82.2.342
PMID:16087977
Abstract

BACKGROUND

Inflammation and malnutrition are common in chronic kidney disease (CKD) patients, and plasma concentrations of free amino acids (AAs) in these patients are often abnormal. Malnutrition contributes to alterations in AA concentrations.

OBJECTIVE

The objective was to study the effects of inflammation on plasma AA concentrations.

DESIGN

Concentrations of plasma AAs, serum albumin, and several inflammatory markers were analyzed in 200 fasting, nondiabetic CKD patients who were close to the start of renal replacement therapy. The nutritional status of these patients was assessed by a subjective global assessment.

RESULTS

The patients with inflammation [C-reactive protein (CRP) concentrations >10 mg/L] or malnutrition had lower AA concentrations than did the patients with no inflammation or malnutrition. The presence of both inflammation and malnutrition was associated with more marked reductions in AA concentrations than was malnutrition alone. Significant inverse correlations were observed between the plasma concentrations of most of the essential and nonessential AAs and inflammatory markers, whereas serum albumin concentrations were positively correlated with several AA concentrations. A stepwise multivariate regression analysis showed that serum CRP concentrations were independently associated with low concentrations of the sums of both nonessential AAs and all AAs. An analysis of all-cause mortality with a Kaplan-Meier test showed that the patients with higher AA concentrations had significantly better survival than did the patients with lower AA concentrations.

CONCLUSIONS

Plasma AA concentrations are low in CKD patients with inflammation and are inversely correlated with concentrations of inflammatory markers. Although inflammation and malnutrition are closely related, CRP concentrations were independently associated with low concentrations of the sums of both nonessential AAs and all AAs, which suggests an independent role of inflammation as a cause of low plasma AA concentrations in CKD patients.

摘要

背景

炎症和营养不良在慢性肾脏病(CKD)患者中很常见,这些患者血浆中游离氨基酸(AA)的浓度常常异常。营养不良会导致氨基酸浓度改变。

目的

研究炎症对血浆氨基酸浓度的影响。

设计

分析了200例即将开始肾脏替代治疗的空腹、非糖尿病CKD患者的血浆氨基酸浓度、血清白蛋白浓度以及几种炎症标志物。通过主观全面评定法评估这些患者的营养状况。

结果

有炎症(C反应蛋白(CRP)浓度>10mg/L)或营养不良的患者,其氨基酸浓度低于无炎症或营养不良的患者。同时存在炎症和营养不良的患者,其氨基酸浓度降低程度比单纯营养不良的患者更明显。观察到大多数必需氨基酸和非必需氨基酸的血浆浓度与炎症标志物之间存在显著负相关,而血清白蛋白浓度与几种氨基酸浓度呈正相关。逐步多元回归分析表明,血清CRP浓度与非必需氨基酸总和以及所有氨基酸总和的低浓度独立相关。采用Kaplan-Meier检验进行的全因死亡率分析显示,氨基酸浓度较高的患者生存率显著高于氨基酸浓度较低的患者。

结论

有炎症的CKD患者血浆氨基酸浓度较低,且与炎症标志物浓度呈负相关。虽然炎症和营养不良密切相关,但CRP浓度与非必需氨基酸总和以及所有氨基酸总和的低浓度独立相关,这表明炎症在CKD患者血浆氨基酸浓度降低中具有独立作用。

相似文献

1
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.炎症导致慢性肾病患者血浆氨基酸浓度降低。
Am J Clin Nutr. 2005 Aug;82(2):342-9. doi: 10.1093/ajcn.82.2.342.
2
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.慢性肾病患者开始透析治疗时高同型半胱氨酸血症与血浆游离氨基酸、炎症生物标志物及死亡率的关系
Am J Kidney Dis. 2004 Sep;44(3):455-65.
3
Serum concentration of amino acids versus nutritional status in hemodialysis patients.血液透析患者血清氨基酸浓度与营养状况的关系
J Ren Nutr. 2008 Mar;18(2):239-47. doi: 10.1053/j.jrn.2007.11.011.
4
End-Stage Renal Disease Patients Lose a Substantial Amount of Amino Acids during Hemodialysis.终末期肾病患者在血液透析过程中会大量流失氨基酸。
J Nutr. 2020 May 1;150(5):1160-1166. doi: 10.1093/jn/nxaa010.
5
Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients.使用聚丙烯腈膜进行血液透析期间的氨基酸损失:透析期间补充氨基酸对非糖尿病患者血浆氨基酸浓度和营养变量的影响。
Am J Clin Nutr. 2000 Mar;71(3):765-73. doi: 10.1093/ajcn/71.3.765.
6
Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.慢性肾病患者中C反应蛋白、白蛋白与心血管疾病的关系
Am J Kidney Dis. 2003 Jul;42(1):44-52. doi: 10.1016/s0272-6386(03)00407-4.
7
C-Reactive protein, a valuable predictive marker in chronic kidney disease.C反应蛋白,慢性肾脏病中的一种重要预测标志物。
Saudi J Kidney Dis Transpl. 2009 Sep;20(5):811-5.
8
The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.循环可溶性 TRAIL 是炎症的负性标志物,与慢性肾脏病患者的死亡风险呈负相关。
Nephrol Dial Transplant. 2010 Aug;25(8):2596-602. doi: 10.1093/ndt/gfq042. Epub 2010 Feb 26.
9
The malnutrition and inflammation axis in pediatric patients with chronic kidney disease.慢性肾病患儿的营养不良与炎症轴
Pediatr Nephrol. 2007 Jun;22(6):864-73. doi: 10.1007/s00467-007-0429-y. Epub 2007 Mar 6.
10
Decreased plasma amino acid concentrations in cats with chronic gastrointestinal diseases and their possible contribution in the inflammatory response.患有慢性胃肠疾病的猫血浆氨基酸浓度降低及其在炎症反应中的可能作用。
Vet Immunol Immunopathol. 2018 Jan;195:1-6. doi: 10.1016/j.vetimm.2017.11.001. Epub 2017 Nov 8.

引用本文的文献

1
Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study.解析1型戈谢病中的代谢变化:一项多组学研究。
J Mol Med (Berl). 2025 Feb;103(2):187-203. doi: 10.1007/s00109-024-02512-x. Epub 2024 Dec 30.
2
Identification of serum biomarkers for chronic kidney disease using serum metabolomics.基于血清代谢组学鉴定慢性肾脏病的血清生物标志物。
Ren Fail. 2024 Dec;46(2):2409346. doi: 10.1080/0886022X.2024.2409346. Epub 2024 Oct 8.
3
Role of the afferent lymph as an immunological conduit to analyze tissue antigenic and inflammatory load.
作为免疫通道的输入淋巴管,用于分析组织抗原和炎症负荷的作用。
Cell Rep. 2024 Jun 25;43(6):114311. doi: 10.1016/j.celrep.2024.114311. Epub 2024 Jun 5.
4
Glycine by enteral route does not improve major clinical outcomes in severe COVID-19: a randomized clinical pilot trial.肠内给予甘氨酸不能改善重症 COVID-19 的主要临床结局:一项随机临床试点试验。
Sci Rep. 2024 May 21;14(1):11566. doi: 10.1038/s41598-024-62321-7.
5
Circulatory histidine levels as predictive indicators of disease activity in takayasu arteritis.循环中组氨酸水平作为大动脉炎疾病活动的预测指标。
Anal Sci Adv. 2021 Mar 20;2(11-12):527-535. doi: 10.1002/ansa.202000181. eCollection 2021 Dec.
6
Serum branched chain amino acids: an effective indicator of diabetic kidney disease.血清支链氨基酸:糖尿病肾病的有效指标。
Front Endocrinol (Lausanne). 2023 Nov 27;14:1269633. doi: 10.3389/fendo.2023.1269633. eCollection 2023.
7
Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies.代谢组学分析作为原发性肾小球肾炎亚型潜在非侵入性生物标志物的研究:荟萃分析。
Sci Rep. 2023 Nov 21;13(1):20325. doi: 10.1038/s41598-023-47800-7.
8
Amino acid metabolism in health and disease.氨基酸代谢与健康和疾病。
Signal Transduct Target Ther. 2023 Sep 13;8(1):345. doi: 10.1038/s41392-023-01569-3.
9
Construction of chronic glomerulonephritis‑related lncRNA‑mRNA regulatory network and lncRNA‑-miRNA‑mRNA ceRNA network by bioinformatics analysis.通过生物信息学分析构建慢性肾小球肾炎相关的长链非编码RNA-信使核糖核酸调控网络和长链非编码RNA-微小核糖核酸-信使核糖核酸竞争性内源RNA网络
Exp Ther Med. 2023 Jul 7;26(2):403. doi: 10.3892/etm.2023.12102. eCollection 2023 Aug.
10
Serum Metabolites Characterization Produced by Cats CKD Affected, at the 1 and 2 Stages, before and after Renal Diet.1期和2期慢性肾病猫在肾脏饮食前后产生的血清代谢物特征
Metabolites. 2022 Dec 27;13(1):43. doi: 10.3390/metabo13010043.